ARROWHEAD PHARMACEUTICALS, INC. Proceeds from Income Tax Refunds
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Proceeds from Income Tax Refunds of $1.37 million for the 6-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2016-05-10
- 2016-03-31: Proceeds from Income Tax Refunds 6 month $1.37M.
| Period end | Proceeds from Income Tax Refunds 6 month |
|---|---|
| 2016-03-31 | $1.37M 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |